Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →24
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,336
Total Claims
$1.4M
Drug Cost
911
Beneficiaries
$1,568
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+9%
Opioid rate vs peers
49.9% vs 45.9% avg
+225%
Cost per patient vs peers
$1,568 vs $483 avg
+26%
Brand preference vs peers
5.2% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
49.9%
Opioid Rate
8,655
Opioid Claims
$977K
Opioid Cost
28.3%
Long-Acting Rate
This provider's opioid prescribing rate of 49.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 905 claims · $611K
Generic: 16,431 claims · $817K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 195 | $193K |
| Oxycodone Hcl/Acetaminophen | 2,424 | $170K |
| Oxycodone Myristate | 126 | $123K |
| Fentanyl | 538 | $79K |
| Hydrocodone/Acetaminophen | 2,258 | $72K |
| Buprenorphine Hcl/Naloxone Hcl | 227 | $67K |
| Tapentadol Hcl | 43 | $54K |
| Buprenorphine | 128 | $46K |
| Morphine Sulfate | 769 | $45K |
| Oxycodone Hcl | 1,090 | $34K |
| Oxymorphone Hcl | 37 | $31K |
| Gabapentin | 1,641 | $29K |
| Tapentadol Hcl | 28 | $27K |
| Linaclotide | 41 | $22K |
| Ondansetron | 54 | $22K |
Prescribing Profile
76
Unique Drugs
24.0
Anomaly Score
Patient Profile
67
Avg Age
60%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About